Jennison Associates LLC Novo Nordisk A S Transaction History
Jennison Associates LLC
- $149 Billion
- Q1 2024
A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 21,084,614 shares of NVO stock, worth $2.85 Billion. This represents 1.82% of its overall portfolio holdings.
Number of Shares
21,084,614
Previous 22,527,772
6.41%
Holding current value
$2.85 Billion
Previous $2.33 Billion
16.17%
% of portfolio
1.82%
Previous 1.75%
Shares
21 transactions
Others Institutions Holding NVO
# of Institutions
1,851Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.86 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.77 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.62 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.6 Billion4.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.8MShares$1.46 Billion2.18% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $305B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...